These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32611637)

  • 41. Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.
    Jacobs HIL; Becker JA; Kwong K; Munera D; Ramirez-Gomez L; Engels-Domínguez N; Sanchez JS; Vila-Castelar C; Baena A; Sperling RA; Johnson KA; Lopera F; Quiroz YT
    Alzheimers Dement; 2023 Jan; 19(1):169-180. PubMed ID: 35298083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease.
    Martinez JE; Pardilla-Delgado E; Guzmán-Vélez E; Vila-Castelar C; Amariglio R; Gatchel J; Aguirre-Acevedo DC; Bocanegra Y; Baena A; Henao E; Tirado V; Muñoz C; Giraldo-Chica M; Lopera F; Quiroz YT
    J Int Neuropsychol Soc; 2022 Jul; 28(6):541-549. PubMed ID: 34187609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
    Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
    Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological function in nondemented carriers of presenilin-1 mutations.
    Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Chavez M; Fairbanks L; Paz F; Varpetian A; Maldonado HC; Macias-Islas MA; Murrell J; Ghetti B; Kawas C
    Neurology; 2005 Aug; 65(4):552-8. PubMed ID: 16116115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.
    Smith R; Wibom M; Pawlik D; Englund E; Hansson O
    JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.
    Braskie MN; Medina LD; Rodriguez-Agudelo Y; Geschwind DH; Macias-Islas MA; Thompson PM; Cummings JL; Bookheimer SY; Ringman JM
    Hum Brain Mapp; 2013 Dec; 34(12):3308-19. PubMed ID: 22806961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
    Sepulveda-Falla D; Glatzel M; Lopera F
    J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
    Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
    JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.
    Norton DJ; Amariglio R; Protas H; Chen K; Aguirre-Acevedo DC; Pulsifer B; Castrillon G; Tirado V; Munoz C; Tariot P; Langbaum JB; Reiman EM; Lopera F; Sperling RA; Quiroz YT
    Neurology; 2017 Oct; 89(14):1464-1470. PubMed ID: 28878053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET/MRI Delivers Multimodal Brain Signature in Alzheimer's Disease with De Novo PSEN1 Mutation.
    Aghakhanyan G; Saur D; Rullmann M; Weise CM; Schroeter ML; Marek K; Jamra RA; Tiepolt S; Strauss M; Scherlach C; Hoffmann KT; Sabri O; Classen J; Barthel H
    Curr Alzheimer Res; 2021; 18(2):178-184. PubMed ID: 33855944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    Quiroz YT; Willment KC; Castrillon G; Muniz M; Lopera F; Budson A; Stern CE
    J Alzheimers Dis; 2015; 47(4):955-64. PubMed ID: 26401774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.